Clinical Trial Update: Adebrelimab Plus Cetuximab and Chemotherapy for Patients With RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating adebrelimab plus cetuximab and chemotherapy in patients with RAS/BRAF wild-type unresectable liver metastases from colorectal cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Cetuximab (cetuximab)

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN